[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IT7948950A0 - Acidi lattamo-n-acetici e loro ammidi procedimento per prepararli e composizioni terapeutiche che licontengono - Google Patents

Acidi lattamo-n-acetici e loro ammidi procedimento per prepararli e composizioni terapeutiche che licontengono

Info

Publication number
IT7948950A0
IT7948950A0 IT7948950A IT4895079A IT7948950A0 IT 7948950 A0 IT7948950 A0 IT 7948950A0 IT 7948950 A IT7948950 A IT 7948950A IT 4895079 A IT4895079 A IT 4895079A IT 7948950 A0 IT7948950 A0 IT 7948950A0
Authority
IT
Italy
Prior art keywords
lactam
amides
preparing
procedure
contain
Prior art date
Application number
IT7948950A
Other languages
English (en)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of IT7948950A0 publication Critical patent/IT7948950A0/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08Oxygen atoms
    • C07D223/10Oxygen atoms attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D227/00Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
    • C07D227/02Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D227/06Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D227/08Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyamides (AREA)
  • Pyridine Compounds (AREA)
IT7948950A 1978-05-08 1979-05-07 Acidi lattamo-n-acetici e loro ammidi procedimento per prepararli e composizioni terapeutiche che licontengono IT7948950A0 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1816078 1978-05-08

Publications (1)

Publication Number Publication Date
IT7948950A0 true IT7948950A0 (it) 1979-05-07

Family

ID=10107678

Family Applications (1)

Application Number Title Priority Date Filing Date
IT7948950A IT7948950A0 (it) 1978-05-08 1979-05-07 Acidi lattamo-n-acetici e loro ammidi procedimento per prepararli e composizioni terapeutiche che licontengono

Country Status (23)

Country Link
US (1) US4221789A (it)
EP (1) EP0005689B1 (it)
JP (1) JPS54154760A (it)
AT (1) ATE27T1 (it)
AU (1) AU522815B2 (it)
BE (1) BE876067A (it)
CA (1) CA1119593A (it)
DE (2) DE2960194D1 (it)
DK (1) DK150064C (it)
ES (1) ES480299A1 (it)
FI (1) FI66602C (it)
FR (1) FR2425433A1 (it)
GR (1) GR67631B (it)
HU (1) HU178362B (it)
IT (1) IT7948950A0 (it)
NL (1) NL7903536A (it)
NO (1) NO150639C (it)
PL (1) PL117056B1 (it)
PT (1) PT69582A (it)
SE (1) SE7903864L (it)
SU (2) SU1093245A3 (it)
YU (1) YU41340B (it)
ZA (1) ZA792175B (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2944456C2 (de) * 1979-11-03 1982-04-01 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von N-α -Alkoxyalkyl-carbonsäureamiden
US4396616A (en) * 1981-09-04 1983-08-02 Merck & Co., Inc. Substituted enantholactam derivatives as antihypertensives
DE3361609D1 (en) * 1982-03-24 1986-02-06 Prodes Sa New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
US4608201A (en) * 1984-05-21 1986-08-26 Ppg Industries, Inc. Process for preparing lactam imides
CA1322199C (en) * 1987-07-15 1993-09-14 Masami Eigyo N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia
IT1242043B (it) * 1990-12-21 1994-02-02 Sigma Tau Ind Farmaceuti Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono.
IT1245870B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti 3-acilammino-2-pirrolidinoni quali attivatori dei processi di appremdimento e della memoria e composizioni farmaceutiche comprendenti tali composti
US5510477A (en) * 1994-03-01 1996-04-23 The Procter & Gamble Company Process for the acylation of lactams
AU1369001A (en) * 1995-12-13 2001-03-22 Abbott Laboratories Retroviral protease inhibiting compounds
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
US7834043B2 (en) 2003-12-11 2010-11-16 Abbott Laboratories HIV protease inhibiting compounds
CN102227217A (zh) * 2008-10-16 2011-10-26 约翰斯.霍普金斯大学 改善认知功能的方法和组合物
CN102905532A (zh) * 2010-02-09 2013-01-30 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
ES2881081T3 (es) 2013-03-15 2021-11-26 Agenebio Inc Procedimientos y composiciones para mejorar la función cognitiva
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
AU2016268096B2 (en) 2015-05-22 2021-04-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
EP3331872B1 (en) 2015-08-05 2019-09-25 Bristol-Myers Squibb Company Novel substituted glycine derived fxia inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2657215A (en) * 1950-03-10 1953-10-27 Goodrich Co B F Method for the preparation of novel n-(2-carboxyalkyl) succinimides
DE1081896B (de) * 1959-03-28 1960-05-19 Bayer Ag Verfahren zur Herstellung von ª‡-Amino-ª‰-hydroxycarbonsaeuren
GB1039113A (en) 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
GB1309692A (en) 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
US3751262A (en) * 1970-06-30 1973-08-07 Allied Chem Ruminant feed supplement
GB1539817A (en) * 1976-10-22 1979-02-07 Ucb Sa N-substituted lactams

Also Published As

Publication number Publication date
JPS6220982B2 (it) 1987-05-11
FI66602C (fi) 1984-11-12
SE7903864L (sv) 1979-11-09
YU106979A (en) 1983-04-30
NL7903536A (nl) 1979-11-12
AU522815B2 (en) 1982-06-24
NO150639B (no) 1984-08-13
JPS54154760A (en) 1979-12-06
FR2425433A1 (fr) 1979-12-07
CA1119593A (en) 1982-03-09
ZA792175B (en) 1980-05-28
NO791477L (no) 1979-11-09
SU1093245A3 (ru) 1984-05-15
AU4681679A (en) 1979-11-15
PL117056B1 (en) 1981-07-31
FI791421A (fi) 1979-11-09
US4221789A (en) 1980-09-09
DK150064B (da) 1986-12-01
SU969701A1 (ru) 1982-10-30
EP0005689B1 (fr) 1981-03-18
YU41340B (en) 1987-02-28
DE2960194D1 (en) 1981-04-16
GR67631B (it) 1981-09-01
ES480299A1 (es) 1980-08-16
NO150639C (no) 1984-11-21
DK182379A (da) 1979-11-09
DK150064C (da) 1987-06-15
DE2918523A1 (de) 1979-11-15
FI66602B (fi) 1984-07-31
BE876067A (fr) 1979-11-07
PT69582A (fr) 1979-06-01
HU178362B (en) 1982-04-28
PL215420A1 (it) 1980-02-11
EP0005689A1 (fr) 1979-11-28
ATE27T1 (de) 1981-04-15

Similar Documents

Publication Publication Date Title
IT7948950A0 (it) Acidi lattamo-n-acetici e loro ammidi procedimento per prepararli e composizioni terapeutiche che licontengono
IT1194900B (it) N-(fenossialchile)immidazoli,relative composizioni farmaceutiche e procedimento per la loro fabbricazione
IT1115158B (it) Acidi 4-tiazolidini-carbossilici anti-ipertenzione
IT1141287B (it) Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
IT1120442B (it) Procedimento per produrre acidi arilpiruvici
IT1194632B (it) Acidi n-(idrossimetil)-amminoalcan-difosfonici e loro impiego come stabilizzanti
IT1162481B (it) Acidi 4-(5-fluorometil-2-piridil-ossi)-fenossi-valerici e loro derivti composizioni erbicide che li contengono e procedimento per applicarli
IT1069080B (it) Acidi alchilammidoalcansolfonici fluorurati procedimento per produrli e composizioni che li contengono
IT1122006B (it) Procedimento per preparare diesteri di acidi dicarbossilici
IT1111198B (it) Procedimento per la preparazione di acidi
IT1076799B (it) Acidi n-fosfon-metilen-monoammino-alcan-mono- e -poli-fosfonici oppure acidi n-fosfon-metilen-diammino-alcan-polifosfonici e anche procedimenti per la loro preparazione
IT1078751B (it) Acidi fenossialchilcarbossilici e processo per la loro preparazione
IT1070945B (it) Acidi fenossialchilcarbossilici e processo per la loro preparazione
IT7920206A0 (it) Nuove ammidi derivate da acidi pirimidin-5-carbossilici, loro preparazione e loro applicazione in terapia.
IT1086375B (it) Esteri di acidi pirimidinil-tion-fosfonici alcossi sostituiti,procedimento per la loro preparazione e loro impiego come insetticidi e come acaricidi
IT1064126B (it) Piridazoni sostituiti procedimento per la loro produzione e loro impiego come prodotti erbicidi
IT1109778B (it) Prodotti microbicidi e procedimento per la loro preparazione
IT7950714A0 (it) Ariltrifluoroetanoli procedimento per prepararli e composizioni farmaceutiche che li contengono
IT1128163B (it) Procedimento per la preparazione di acidi alcanoici
IT1110819B (it) Procedimento per la preparazione di acidi benzen-carbossilici
IT1109779B (it) Prodotti microbicidi e procedimento per la loro preparazione
IT7831447A0 (it) Acidi acil-idrocarbilammino-alcanoici, loro preparazione e loro impiego e anche prodotti medicinali che licontengono.
IT1206985B (it) Amminoalchilguanidine sostituite eprocedimento per la loro preparazione
IT7822729A0 (it) Acidi 5-solfamoilortanilici e processo per la loro preparazione.
IT1098368B (it) Acidi n-carbossialcan-amminoalcan-difosfonici,acidi n-carbossi-alcanaza-cicloalcan-difosfonici e acidi n-carbossialcan-ammino-arilalcan-difosfonici,e processo per la loro preparazione